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Abstract
Jo Lynn Jeter is a 2004 graduate of the University of Oklahoma College of Law. She was a
member of the Oklahoma Journal of Law and Technology during the 2003-2004 academic year.
Ms. Jeter wrote this eBrief while working on the Project on Intellectual Property Rights in Living
Matter under the direction of Professor Drew Kershen. Below, Ms. Jeter discusses the
administrative regulations and policies pertaining to patents on living matter. The United States
Patent and Trademark Office (USPTO) has been delegated considerable discretion by Congress
to oversee the patent process. It is essential for one seeking a patent or patent-like protection in
the United States to become familiar with the contents of the Manual on Patent Examining
Procedure (MPEP) and various guidelines issued by USPTO. This eBrief provides helpful
insight into these topics.
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I.

Introduction

The U.S. Constitution authorizes Congress “to promote the Progress of Science and
useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their
respective Writings and Discoveries.” 1 Within the scope of this clause, Congress establishes
conditions and tests for patentability through federal statutes. The conditions for patentability
must be strict enough to justify the issuance of a limited monopoly that comes with a patent, but
lenient enough to encourage and promote innovation. In order to create a consistent policy
regarding the ease or difficulty of receiving patents under patent statutes, the United States
Patent and Trademark Office issues “Guidelines” to direct its office personnel. The Guidelines
establish policies for examining a patent application.

1

U.S. CONST. art. I, § 8, cl. 8.
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II.

USPTO POLICY AND AGRICULTURAL BIOTECHNOLOGY

There are three means by which one may receive federal statutory intellectual property
protection for living matter: The Plant Patent Act of 1930 (“PPA”), 2 Plant Variety Protection
Act of 1970 (“PVPA”) 3 or Patent Act of 1952. 4 The Patent Act’s patentable subject matter
overlaps with the protected subject matter under the PPA and the PVPA.

However, the

availability of one form of statutory protection does not preclude the availability of protection
under another form. 5 In order to receive protection under one of these Acts, the respective
statutory requirements must be met. The PPA applies only to certain asexually reproduced
plants. 6 The conditions for obtaining a patent under the PPA are distinctiveness, novelty, nonobviousness and a description “as complete as is reasonably possible.” 7 Conversely, the PVPA
applies to sexually reproduced plants. 8 To qualify for a PVPA certificate, the variety must be
new, distinct, uniform and stable. 9

The Patent Act of 1952 conveys patent protection to

2

35 U.S.C. §§ 161-164 (2000).
7 U.S.C. §§ 2321-2582 (2000).
4
35 U.S.C. §§ 101-318 (2000).
5
See J.E.M. Ag Supply, Inc. v. Pioneer Hi-bred Int’l., Inc., 534 U.S. 124, 132, 145 (2001) (holding plants patentable
under the Patent Act of 1952, despite their coverage under the PPA and PVPA). Examining the text of the Acts and
the legislative history, neither of the plant-specific Acts expressly excludes any plant subject matter from protection
under the general patent law. Id. at 134-44.
6
See 35 U.S.C. § 161 (2000) (emphasis added).
7
See 35 U.S.C. §§ 161-164 (2000); see also Yoder Bros., Inc. v. California-Florida Plant Corp., 537 F.2d 1347,
1377 (5th Cir. 1976) (“novelty” refers to newness in its conception); Jacobson Bros., Inc. v. United States, 512 F.2d
1065, 1068 (1975) (“non-obviousness” is a prerequisite of any patent and simply requires that the creation or
improvement not be obvious at the time the invention was made); Yoder, 537 F.2d at 1379 (“We think that the most
promising approach toward the obviousness requirement for plant patents is reference to the underlying
constitutional standard that it codifies namely, invention”); In re Greer, 484 F.2d 488, 490-91 (Cust. & Pat. App.
1973) (the U.S. Court of Customs and Patent Appeals has interpreted the description provision “as complete as is
reasonably possible” to mean that there is no requirement for a “how-to-make” disclosure in a plant patent
application); Ex parte Solomons, 201 U.S.P.Q. (BNA) 42 (1978) (the less strict description requirement is due to the
impossibility of producing the patented plant from a description, because it must be asexually reproduced).
8
7 U.S.C. § 2402 (2000) (emphasis added).
9
See id. § 2402(a)(1) (emphasis added) (“New” if “on the date of filing the application for plant variety protection,
propagating or harvested material of the variety has not been sold or otherwise disposed of to other persons, by or
with the consent of the breeder, or the successor in interest of the breeder, for purposes of exploitation of the
variety); id. § 2402(a)(2) (“Distinct” if the “variety is clearly distinguishable from any other variety the existence of
which is publicly known or a matter of common knowledge at the time of filing of the application”); id. § 2402(a)(3)
3
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“whoever invents or discovers any new and useful process, machine, manufacture or
composition of matter, or any new and useful improvement thereof.” 10 “Manufacture” and
“composition of matter” include live, human-made creations, such as microorganisms and
plants. 11 Further, the Patent Act requires patentable subject matter to be new, useful, and nonobvious. 12

In addition, the applicant for a utility patent must meet stringent description

requirements. 13
It is more difficult to obtain a utility patent for a plant than to obtain a Plant Patent
or a PVPA certificate, due to the additional requirement of usefulness and the more stringent
description requirement. However, a utility patent may be more desirable because of its greater
scope of protection. 14 Thus, the Patent Act may often be an applicant’s first choice of protection
for plant creations if the statutory requirements can be met.

(“Uniformity” requires the variety be “describable, predictable and commercially acceptable); id. § 2402(a)(4)
(“Stability” requires the variety “remain unchanged with regard to the essential and distinctive characteristics of the
variety” upon reproduction).
10
35 U.S.C. § 101.
11
See Diamond v. Chakrabarty, 447 U.S. 303, 308 (1980) (the U.S. Supreme Court, after examining the text and
legislative history of the Patent Act, gave the terms “manufacture” and “composition of matter” a broad
interpretation to include a live, human-made microorganism); Id. at 309-10 (the Court reiterated that discoveries in
nature are not patentable, but stated that a non-naturally occurring manufacture or composition of matter that is a
product of human ingenuity having a distinctive name, character and use is patentable subject matter under section
101 of the Act, even if it is living matter); see also In re Hibberd, 227 U.S.P.Q. (BNA) 443 (1985) (the broad
interpretation of “manufacture” and “composition of matter” within the Act led to the U.S. Patent and Trademark
Office (USPTO) issuing utility patents for plants, plant parts and seeds); J.E.M. Ag Supply, Inc. v. Pioneer Hi-bred
Int’l., Inc., 534 U.S. 124, 127 (2001) (the U.S. Supreme Court later affirmed the USPTO’s issuing of patents for
plants, plant parts as seeds in a clear ruling that plants were patentable subject matter under the general Patent Act).
12
See 35 U.S.C. §§ 101-103 (2000) (emphasis added). For a better understanding of what these specific
requirements entail, see § 102(a) (providing that a plant is considered new if it was not known or used by others
before its discovery); Yoder, 537 F.2d at 1378 (to be new, the plant must be “one that literally had not existed
before, rather than one that had existed in nature but was newly found”); Imperial Chem. Indus., PLC v. Henkel
Corp., 545 F. Supp. 635, 644-45 (1982) (The “product of a patented process is useful if it may serve some
identifiable purpose”); Graham v. John Deere Co. of Kansas City, 383 U.S. 1, 17 (1966) (the “emphasis on nonobviousness is one of inquiry, not quality”); Yoder, 537 F.2d at 1378-79 (Obviousness serves as “Congress’
articulation of the constitutional standards of invention.” There must be an actual invention, and non-obviousness
requires the invention entail a degree of skill and ingenuity greater than that possessed by one with an ordinary level
of knowledge in the practice or trade).
13
See 35 U.S.C. § 112 (2000).
14
Unlike the PVPA, the Patent Act does not contain exemptions that limit the scope of protection. The PVPA
contains three exemptions from infringement limiting its scope in protection: (1) Public Interest Exemption, 7
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In order to determine whether a patent applicant has met the stringent statutory
requirements of the Patent Act, the United States Trademark and Patent Office (“USPTO”) has
issued “Guidelines” establishing the policies and procedures for evaluating patent applications.
The Guidelines assist USPTO personnel in determining whether to issue a patent under the
Patent Act.

The Guidelines do not alter any statutory requirements and do not constitute

substantive rulemaking; thus, they do not have the force of the law, but merely assist in carrying
out the law. 15 In 2001, the USPTO issued two separate Guidelines relating to the requirements
of utility patents. The first Guidelines address the “utility” requirement; the second Guidelines
address the “written description” requirement. These Guidelines provide insight into USPTO
policy regarding patent applications as discussed in detail below.
A.

“Utility” Examination Guidelines
The Utility Examination Guidelines 16 establish the policies and procedures for evaluating

whether a patent application complies with the utility requirements of 35 U.S.C. §§ 101 and
112. 17 In determining whether the utility requirements have been met, the Guidelines instruct
office personnel to do the following:
1. Read the claims and the supporting written description; 2. Review the claims and the
supporting written description to determine if the applicant has asserted for the claimed

U.S.C. § 2404; (2) Research Exemption, 7 U.S.C. § 2544; and (3) the Farmer’s Exemption, 7 U.S.C. § 2543. Also,
the PVPA limits protection to a single variety and the PPA limits protection to a specific plant; the Patent Act does
not. Specifically, the PVPA protection falls short of a utility patent because a breeder can use a plant that is
protected by a PVP certificate to “develop” a new inbred line while he cannot use a plant patented under the general
Patent Act for such a purpose. See 7 U.S.C. § 2541(a)(4), stating that infringement includes “use of the variety in
producing (as distinguished form developing) a hybrid or different variety therefrom”.
15
66 Fed. Reg. 1092, 1097-98 (Jan. 5, 2001); 66 Fed. Reg. 1099, 1104 (Jan. 5, 2001).
16
66 Fed. Reg. 1092 (Jan. 5, 2001). This revision supersedes the Revised Interim Utility Guidelines that were
published at 64 Fed. Reg. 71,440 (Dec. 21, 1999) and correction at 65 Fed. Reg. 3425 (Jan. 21, 2000).
17
66 Fed. Reg. at 1098. Title 35 U.S.C. § 101 states that “whoever invents or discovers any new and useful process,
machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent
therefore, subject to the conditions and requirements of this title.” Title 35 U.S.C. § 112 states that “the
specification shall contain a written description of the invention, and of the manner and process of making and using
it, in such full, clear, concise and exact terms as to enable any person skilled in the art to which it pertains, or with
which it is most nearly connected, to make and use the same….”
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invention any specific and substantial utility that is credible; 3. Any rejection based on
lack of utility should include a detailed explanation why the claimed invention has no
specific and substantial credible utility… the examiner should provide documentary
evidence regardless of publication date to support the factual basis of the prima facie
showing of no specific and substantial credible utility… 4. A rejection based on lack of
utility should not be maintained if an asserted utility for the claimed invention would be
considered specific, substantial, and credible by a person of ordinary skill in the art in
view of all evidence of record. 18
Under instruction number one, if at any time an examiner finds it “readily apparent” that
a claimed invention has a “well-established utility,” the examiner should not impose a rejection
based on lack of utility. 19 Furthermore, “an invention has a well-established utility: 1. if a person
of ordinary skill in the art would immediately appreciate why the invention is useful based on the
characteristics of the invention, and 2. the utility is specific, substantial, and credible.” 20 Under
instruction number two, an examiner cannot reject the patent application based on lack of utility
if the applicant has asserted a “specific and substantial utility that is credible.” 21 An applicant
has asserted a “specific and substantial utility that is credible” if “the claimed invention is useful
for any particular practical purpose and the assertion would be considered credible by a person of
ordinary skill in the art.” 22 To satisfy the utility requirement, only one credible assertion of
specific and substantial utility is required for each claimed invention. 23
Accordingly, there are two means by which an examiner may find the “utility”
requirement satisfied. First, if the claimed invention has a readily apparent well-established
utility; or second, if the applicant asserts any specific and substantial utility for the claimed

18

66 Fed. Reg. at 1098.
Id.
20
Id.
21
Id.
22
Id. The specific and substantial utility requirement “excludes ‘throw-away,’ ‘insubstantial,’ or ‘nonspecific’
utilities, such as the use of a complex invention as landfill, as a way of satisfying the utility requirement,” Id.
“Credibility is assessed from the perspective of one of ordinary skill in the art in view of the disclosure and any
other evidence of record (e.g., test data, affidavits or declarations from experts in the art, patents or printed
publications) that is probative of the applicant’s assertions,” Id.
23
Id.
19
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invention that is credible. 24 If neither of these two requirements is satisfied, office personnel are
instructed to reject the application. 25 If the application is rejected, the burden shifts to the
applicant to present evidence in order to prove there is in fact a specific and substantial utility
that one of ordinary skill in the art would have recognized.26 An applicant may amend his or her
claims rebutting the basis for the examiner’s rejection, to which an examiner must fully consider
and respond. 27
Upon rejecting an application, instruction number three requires office personnel to
include a “detailed explanation” of why there is no specific and substantial credible utility. 28
Also, “whenever possible, the examiner should provide documentary evidence… to support the
factual basis… of no specific and substantial credible utility. If documentary evidence is not
available, the examiner should specifically explain the scientific basis for his or her factual
conclusions.” 29 Finally, the Guidelines instruct office personnel to “treat as a true statement of
fact made by an applicant in relation to an asserted utility, unless countervailing evidence can be
provided that shows that one of ordinary shill in the art would have a legitimate basis to doubt
the credibility of such a statement. Similarly, office personnel must accept an opinion from a
qualified expert that is based upon relevant facts whose accuracy is not being questioned.” 30
Given these Guidelines, it is evident that the applicant is given wide latitude in
establishing the utility of a claimed invention. An applicant may assert the claimed invention’s
utility or, if the invention’s utility is well-established and readily apparent, the examiner must

24

Id.
Id.
26
Id.
27
Id. at 1099.
28
Id. at 1098.
29
Id.
30
Id. at 1098-99.
25
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accept the application as sufficiently establishing utility, even if no specific and substantial utility
has been asserted. Also, if an application is rejected, the applicant may rebut the findings with
any reasoning, arguments, evidence or publications in order to have the application reconsidered.
The office must fully reconsider and respond to the rebuttal. 31
Specifically, one seeking patent protection for living matter under the Patent Act must
assert a specific, substantial and credible utility. The applicant need not assert commercial
success, but must assert that the claimed invention serves some identifiable purpose. 32 For
example, an applicant may assert the claimed invention requires less pesticide or herbicide for
growing crops, is useful in developing pharmaceutical drugs, is a necessary element of a
laboratory experiment or study, or is more environmentally friendly than its competition. These,
of course, are only a few examples of the many possible uses an applicant may assert.
B.

“Written Description” Requirement Guidelines
The Guidelines for Examination of Patent Applications Under the 35 U.S.C. § 112, 1:

Written Description Requirement 33 establish the policies and procedures for evaluating whether a
Patent Act application meets the written description requirements. An applicant is required to
provide “a written description of the invention, and of the manner and process of making and
using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to
which it pertains… to make and use the same.” 34 Thus, there are two distinct description
requirements: 1. the “written description requirement,” the purpose of which is to confirm the
inventor had possession of what is claimed and actually invented what is claimed; and 2. the

31

Id. at 1099.
See Imperial Chem. Indus., PLC v. Henkel Corp., 545 F. Supp. 635, 645 (1982).
33
66 Fed. Reg. 1099 (Jan 5, 2001). These Guidelines supersede the “Revised Interim Guidelines for Examination of
Patent Applications Under the 35 U.S.C. § 112, 1 ‘Written Description’ Requirement” that were published in the
Federal Register at 64 Fed. Reg. 71,427 (Dec. 21, 1999).
34
35 U.S.C. § 112 (2000).
32
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“enablement requirement,” which ensures “the inventor conveys to others how to make and use
the claimed invention.” 35 These Guidelines address only the first aspect of the description
requirement: the written description requirement.
To satisfy the written description requirement, one must “describe the claimed invention
in sufficient detail that one skilled in the art can reasonably conclude that the inventor had
possession of the claimed invention.” 36 The Guidelines provide that “whether the description
requirement is met is a question of fact that must be determined on a case-by-case basis.” 37 With
this in mind, the Guidelines issue the following instructions to USPTO personnel:
1. For each claim, determine what the claim as a whole covers; 2. Review the entire
application to understand how [the] applicant provides support for the claimed invention
including each element and/or step; and 3. Determine whether there is sufficient written
description to inform a skilled artisan that the applicant was in possession of the claimed
invention as a whole at the time the application was filed. 38
Under the first instruction, the examiner must analyze each claim separately, and give it
the “broadest reasonable interpretation in light of and consistent with the written description.” 39
The examiner must determine what the claim as a whole covers, and the entire claim must satisfy
the written description requirements. 40 Next, under the second instruction the examiner must
“compare the scope of the claim with the scope of the description” to determine whether the
description qualifications have been met from the standpoint of one skilled in the art. 41 Finally,
the third instruction directs the examiner to determine if the description is sufficient enough to
make clear to one skilled in the art that the applicant was in possession of the claimed

35

66 Fed. Reg. at 1104-05.
Id. at 1104.
37
Id. at 1105.
38
Id. at 1105-07.
39
Id. at 1105.
40
Id.
41
Id.
36
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invention. 42 An applicant may show possession of the claimed invention through a number of
methods, such as describing an actual reduction to practice; 43 disclosing detailed drawings or
structural chemical formulas; or describing distinguishing identifying characteristics. 44

An

applicant may use words, structures, figures, diagrams or formulas. 45 The applicant’s primary
goal is to sufficiently describe the invention in order to show possession of the claimed invention
to one skilled in the art; however, “an inventor does not need to know how or why the invention
works in order to obtain a patent.” 46
For an applicant seeking patent protection for a plant, a description of an actual reduction
to practice may be the most practical way to show possession of the claimed invention; for
example, “description of an actual reduction to practice of a biological material is shown by
specifically describing a deposit” made in accordance with the federal regulations. 47 However,
“[t]he description must be sufficient to permit verification that the deposited biological material
is in fact that disclosed.”48 The deposit is not a substitute for the written description requirement,
but rather may serve as a supplement to an applicant’s disclosure for the written description
requirement. Biological material includes “material that is capable of self-replication, either

42

Id.
“A specification may describe an actual reduction to practice by showing that the inventor constructed an
embodiment or performed a process that met all the limitations of the claim and determined that the invention would
work for its intended purpose. Description of an actual reduction to practice of a biological material may be shown
by specifically describing a deposit made in accordance with the requirements of 37 CFR 1.801 et seq,” Id.
44
Id. at 1104, 1105.
45
Id. at 1104.
46
See Newman v. Quigg, 877 F.2d 1575, 1581 (1989).
47
66 Fed. Reg. at 1105; see 37 C.F.R. § 1.801-1.809 (setting forth examining procedures and conditions of deposits
of biological matter). See generally MANUAL OF PATENT EXAMINING PROCEDURE ch. 2400 (Biotechnology)
(providing guidance on the practices and procedures for implementation of the deposit rules), available at
http://www.uspto.gov/web/offices/pac/mpep/mpep_e8_2400_508.pdf.
48
Deposit of Biological Materials for Patent Purposes, Final Rule, 54 Fed. Reg. 34,864, 34,880 (Aug. 22, 1989).
43
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directly or indirectly.” 49

Thus, if the applicant seeks patent protection for a claimed plant

invention, he or she would more than likely deposit seed.
Overall, the Guidelines reflect a USPTO policy in favor of determining that an
application satisfies the description requirements. For example, the Guidelines provide that
“there is a strong presumption that an adequate written description of the claimed invention is
present in the specifications as filed” and “rejection of an original claim for lack of written
description should be rare.” 50

Further, the “examiner has the initial burden” of presenting

reasons why the written description requirements are not met. 51 The Guidelines also state that
the office should “clearly communicate the findings, conclusions, and reasons which support
them,” and “when possible, the office… should offer helpful suggestions on how to overcome
rejections.” 52
An applicant must also fulfill the enablement requirement, an additional aspect of the
description requirement not addressed by the Guidelines. To fulfill the enablement requirement,
an applicant must provide “a written description of the invention, and of the manner and process
of making and using it, in such full, clear, concise, and exact terms as to enable any person
skilled in the art… to make and use the same.” 53 The federal regulations permit a deposit of

49

37 C.F.R. § 1.801 (1989). “Direct Self-replication includes those situations where the biological material
reproduces by itself,” 54 Fed. Reg. 34,864, 34,874 (Aug. 22, 1989). “Representative examples (of self-replicating
biological material) include bacteria, fungi including yeast, algae, protozoa, eukaryotic cells, cell lines, hybridomas,
plasmids, viruses, plant tissue cells, lichens and seeds.” 37 C.F.R. 1.801. “Indirect self-replication is meant to
include those situations where the biological material is only capable of replication when another self-replicating
biological material is present.” 54 Fed. Reg. at 34,874. “Viruses, vectors, cell organelles and other non-living
material existing in and reproducible from a living cell may be deposited by deposit of the host cell capable of
reproducing the non-living material.” 37 C.F.R. 1.801. The lists of representative examples are not intended to be
mutually exclusive and whether a biological material is sufficient to comply with 35 U.S.C. § 112 must be
determined on a case-by-case basis. 54 Fed. Reg. at 34,874.
50
Id. at 1105.
51
Id.
52
Id. at 1107.
53
35 U.S.C. § 112 (2000).
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biological material to be referenced in a patent application where an invention is, or relies on,
biological material. 54 Thus, similar to the possession requirement addressed above, a deposit of
biological material in accordance with federal regulations may be necessary for fulfilling the
enablement requirement. The deposit of plant material together with the written specification
must enable those skilled in the art to make and use the claimed invention. 55 The examiner has
the initial burden of establishing a reasonable basis to question the enablement provided by the
applicant. 56
C.

“Novelty” and “Non-Obviousness” Requirements
The Guidelines comprise only two conditions for patentability under the Patent Act: the

utility requirement and written description requirement. The applicant must also assert and
fulfill the requirements of novelty and non-obviousness.57

A plant is considered new if it

“literally had not existed before, rather than one that had existed in nature but was newly
found.” 58 A plant must also be non-obvious. Obviousness serves as “Congress’ articulation of
the constitutional standards of invention.” 59

There must be an actual invention, and non-

obviousness requires the invention to entail a degree of skill and ingenuity greater than that
possessed by one with an ordinary level of knowledge in the practice or trade. 60 The USPTO
provides that all of the aspects of a claim must be considered when weighing the differences

54

37 C.F.R. § 1.802 (1989).
See 35 U.S.C. § 112.
56
See In re Wright, 999 F.2d 1557, 1562 (1993) (examiner must provide a reasonable explanation as to why the
scope of protection provided by a claim is not adequately enabled by the disclosure).
57
35 U.S.C. §§ 101-103 (2000).
58
Yoder Bros., Inc. v. California-Florida Plant Corp., 537 F.2d 1347, 1378 (1976).
59
Id.
60
Id. at 1379.
55
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between a claimed invention and the prior art when determining the obviousness of a process or
method claim. 61
III.

Conclusion

One seeking intellectual property protection for living matter will more than likely seek a
utility patent under the Patent Act if the requirements can be met, because the Act provides a
greater scope of protection. Before applying for such a patent, an applicant should consult the
Guidelines provided by the USPTO in order to increase the likelihood of success in receiving a
patent. While the Guidelines do not cover all the requirements under the Patent Act, they
provide patent examiners with procedures and policies for analyzing the most problematic areas
of patents: the utility and written description requirements. The Guidelines provide an overall
policy in favor of issuing patents if the statutory requirements are met through presumptions in
favor of the applicant and cooperative assistance. Also, upon applying for a patent, one should
consult the Manual of Patent Examining Procedure (“MPEP”) issued by the USPTO, which
contains the basic requirements and standards of obtaining a patent. The MPEP is used by
USPTO office personnel and is encouraged for use by applicants. Chapter 2400 of the MPEP
provides a thorough guidance on the practices and procedures for depositing biological
material. 62

61

See Manual of Patent Examining Procedure § 2143.03.
The Manual of Patent Examining Procedure can be found at
http://www.uspto.gov/web/offices/pac/mpep/mpep_e8_2004_508.pdf.
62
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